BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

178 related articles for article (PubMed ID: 36810796)

  • 1. Prevalence of IRF4 rearrangement in large B-cell lymphomas of the Waldeyer's ring in adults.
    Streich S; Frauenfeld L; Otto F; Mankel B; Bonzheim I; Fend F; Quintanilla-Martinez L
    Virchows Arch; 2023 Mar; 482(3):551-560. PubMed ID: 36810796
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Diffuse large B-cell lymphomas in adults with aberrant coexpression of CD10, BCL6, and MUM1 are enriched in IRF4 rearrangements.
    Frauenfeld L; Castrejon-de-Anta N; Ramis-Zaldivar JE; Streich S; Salmerón-Villalobos J; Otto F; Mayer AK; Steinhilber J; Pinyol M; Mankel B; Ramsower C; Bonzheim I; Fend F; Rimsza LM; Salaverria I; Campo E; Balagué O; Quintanilla-Martinez L
    Blood Adv; 2022 Apr; 6(7):2361-2372. PubMed ID: 34654055
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Large B-cell lymphoma with IRF4 gene rearrangements: Differences in clinicopathologic, immunophenotypic and cytogenetic features between pediatric and adult patients.
    Berg HE; Peterson JF; Lee HE; McPhail ED
    Hum Pathol; 2023 Jan; 131():108-115. PubMed ID: 36470475
    [TBL] [Abstract][Full Text] [Related]  

  • 4. [Diagnostic and therapeutic values of interphase fluorescence in situ hybridization in B-cell lymphomas: a clinicopathologic analysis of 604 cases].
    Chen M; Yang JL; Zhao S; Liu WP; Li GD; Ye YX; Yan JQ; Zhang WY
    Zhonghua Bing Li Xue Za Zhi; 2018 Dec; 47(12):920-925. PubMed ID: 30522172
    [No Abstract]   [Full Text] [Related]  

  • 5. Distinct molecular profile of IRF4-rearranged large B-cell lymphoma.
    Ramis-Zaldivar JE; Gonzalez-Farré B; Balagué O; Celis V; Nadeu F; Salmerón-Villalobos J; Andrés M; Martin-Guerrero I; Garrido-Pontnou M; Gaafar A; Suñol M; Bárcena C; Garcia-Bragado F; Andión M; Azorín D; Astigarraga I; Sagaseta de Ilurdoz M; Sábado C; Gallego S; Verdú-Amorós J; Fernandez-Delgado R; Perez V; Tapia G; Mozos A; Torrent M; Solano-Páez P; Rivas-Delgado A; Dlouhy I; Clot G; Enjuanes A; López-Guillermo A; Galera P; Oberley MJ; Maguire A; Ramsower C; Rimsza LM; Quintanilla-Martinez L; Jaffe ES; Campo E; Salaverria I
    Blood; 2020 Jan; 135(4):274-286. PubMed ID: 31738823
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Reclassification of diffuse large B cell lymphoma to large B cell lymphoma with IRF4 rearrangement in an adult population.
    Hesius EAM; van Laar L; Oosterveld M; van Spriel AB; Scheijen B; Leeuwis JW; Marres HAM; Groenen PJTA; Stevens WBC; van der Spek E; van den Brule AJC; Hoevenaars BM; Hebeda KM; van den Brand M
    Histopathology; 2023 Jun; 82(7):1013-1020. PubMed ID: 36779226
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Follicular lymphoma and diffuse large B-cell lymphoma with BCL2 and IRF4 rearrangements in adult patients.
    Yuan J; Liu H; Hu S; Miranda RN; Xu X; Bayerl MG; Artymiuk CJ; Berg H; King RL; Shi M; He R; Viswanatha D; Medeiros LJ; McPhail ED
    Hum Pathol; 2023 Nov; 141():22-29. PubMed ID: 37634651
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Emerging entities: high-grade/large B-cell lymphoma with 11q aberration, large B-cell lymphoma with IRF4 rearrangement, and new molecular subgroups in large B-cell lymphomas. A report of the 2022 EA4HP/SH lymphoma workshop.
    Quintanilla-Martinez L; Laurent C; Soma L; Ng SB; Climent F; Ondrejka SL; Zamo A; Wotherspoon A; de Leval L; Dirnhofer S; Leoncini L
    Virchows Arch; 2023 Sep; 483(3):281-298. PubMed ID: 37555980
    [TBL] [Abstract][Full Text] [Related]  

  • 9. B-cell lymphomas involving Waldeyer's ring characterized by distinctive clinical and histopathological features: a comparison of pediatric to adult patients.
    Chen L; Al-Kzayer LF; Liu Y; Liu T
    Oncotarget; 2017 Feb; 8(7):11544-11554. PubMed ID: 28086220
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Ocular adnexal lymphoma: Subtype-specific clinical and genetic features.
    Kirkegaard MK
    Acta Ophthalmol; 2022 Oct; 100 Suppl 270():3-37. PubMed ID: 36196757
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Clinical Significance of
    Ting CY; Chang KM; Kuan JW; Sathar J; Chew LP; Wong OJ; Yusuf Y; Wong L; Samsudin AT; Pana MNBM; Lee SK; Gopal NSR; Puri R; Ong TC; Bahari SK; Goh AS; Teoh CS
    Int J Med Sci; 2019; 16(4):556-566. PubMed ID: 31171907
    [No Abstract]   [Full Text] [Related]  

  • 12. [Large B-cell lymphoma with IRF4 rearrangement: six case reports and a literature review].
    Yu Y; Sun Q; Li CW; Jia YJ; Liu W; Wang TY; Lyu R; Yan YT; An G; Qiu LG; Zou DH; Yi SH
    Zhonghua Xue Ye Xue Za Zhi; 2022 Jun; 43(6):475-480. PubMed ID: 35968590
    [No Abstract]   [Full Text] [Related]  

  • 13. Diffuse large B-cell lymphoma of Waldeyer's ring has distinct clinicopathologic features: a GELA study.
    de Leval L; Bonnet C; Copie-Bergman C; Seidel L; Baia M; Brière J; Molina TJ; Fabiani B; Petrella T; Bosq J; Gisselbrecht C; Siebert R; Tilly H; Haioun C; Fillet G; Gaulard P
    Ann Oncol; 2012 Dec; 23(12):3143-3151. PubMed ID: 22700993
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Prevalence and prognostic value of
    Kirkegaard MK; Minderman M; Sjö LD; Pals ST; Eriksen PRG; Heegaard S
    Br J Ophthalmol; 2023 Apr; 107(4):576-581. PubMed ID: 34706861
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Cell-of-origin classification using the Hans and Lymph2Cx algorithms in primary cutaneous large B-cell lymphomas.
    Schrader AMR; de Groen RAL; Willemze R; Jansen PM; Quint KD; van Wezel T; van Eijk R; Ruano D; Tensen CP; Hauben E; Woei-A-Jin FJSH; Busschots AM; van den Berg A; Diepstra A; Vermeer MH; Vermaat JSP
    Virchows Arch; 2022 Mar; 480(3):667-675. PubMed ID: 35028710
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Simplified algorithm for genetic subtyping in diffuse large B-cell lymphoma.
    Shen R; Fu D; Dong L; Zhang MC; Shi Q; Shi ZY; Cheng S; Wang L; Xu PP; Zhao WL
    Signal Transduct Target Ther; 2023 Apr; 8(1):145. PubMed ID: 37032379
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Multiplex sequencing for EZH2, CD79B, and MYD88 mutations using archival cytospin preparations from B-cell non-Hodgkin lymphoma aspirates previously tested for MYC rearrangement and IGH/BCL2 translocation.
    Santos Gda C; Saieg MA; Ko HM; Geddie WR; Boerner SL; Craddock KJ; Crump M; Bailey D
    Cancer Cytopathol; 2015 Jul; 123(7):413-20. PubMed ID: 25807917
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Colorectal diffuse large B-cell lymphoma: molecular subclassification and prognostic significance of immunoglobulin gene translocation.
    Hori Y; Yamamoto H; Nozaki Y; Torisu T; Fujiwara M; Taguchi K; Nishiyama K; Nakamura S; Kitazono T; Oda Y
    Hum Pathol; 2020 Feb; 96():67-78. PubMed ID: 31734190
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Cell-of-origin determined by both gene expression profiling and immunohistochemistry is the strongest predictor of survival in patients with diffuse large B-cell lymphoma.
    Abdulla M; Hollander P; Pandzic T; Mansouri L; Ednersson SB; Andersson PO; Hultdin M; Fors M; Erlanson M; Degerman S; Petersen HM; Asmar F; Grønbaek K; Enblad G; Cavelier L; Rosenquist R; Amini RM
    Am J Hematol; 2020 Jan; 95(1):57-67. PubMed ID: 31659781
    [TBL] [Abstract][Full Text] [Related]  

  • 20. B-cell lymphomas with MYC/8q24 rearrangements and IGH@BCL2/t(14;18)(q32;q21): an aggressive disease with heterogeneous histology, germinal center B-cell immunophenotype and poor outcome.
    Li S; Lin P; Fayad LE; Lennon PA; Miranda RN; Yin CC; Lin E; Medeiros LJ
    Mod Pathol; 2012 Jan; 25(1):145-56. PubMed ID: 22002575
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 9.